Innovation in the prognostication of chronic lymphocytic leukemia: how far beyond TP53 gene analysis can we go?


Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden; Department of Internal Medicine III, Ulm University, Germany; Division of Hematology, Department of Translational Medicine, Amedeo… (More)
DOI: 10.3324/haematol.2015.139246


2 Figures and Tables